Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
Lyell Immunopharma (LYEL) Stock Price & Analysis
57 Followers
LYEL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.32 - $3.97
Previous Close$2.4
Volume1.99M
Average Volume (3M)924.35K
Market Cap
$609.83M
Enterprise Value$120.50M
Total Cash (Recent Filing)$546.22M
Total Debt (Recent Filing)$56.89M
Price to Earnings (P/E)-2.6
Beta1.30
Next Earnings
May 07, 2024EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding254,096,311
10 Day Avg. Volume1,055,259
30 Day Avg. Volume924,350
Standard Deviation0.25
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.17
Price to Sales (P/S)4691.01
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue926.94
Enterprise Value/Gross Profit926.94
Enterprise Value/Ebitda-0.53
Forecast
1Y Price Target
$6.00Price Target Upside150.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lyell Immunopharma News
Ownership Overview
44.24% Insiders
11.78% Mutual Funds
9.52% Other Institutional Investors
34.46% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LYEL FAQ
What was Lyell Immunopharma’s price range in the past 12 months?
Lyell Immunopharma lowest stock price was $1.32 and its highest was $3.97 in the past 12 months.
What is Lyell Immunopharma’s market cap?
Currently, no data Available
When is Lyell Immunopharma’s upcoming earnings report date?
Lyell Immunopharma’s upcoming earnings report date is May 07, 2024 which is in 18 days.
How were Lyell Immunopharma’s earnings last quarter?
Lyell Immunopharma released its earnings results on Feb 28, 2024. The company reported -$0.205 earnings per share for the quarter, beating the consensus estimate of -$0.23 by $0.025.
Is Lyell Immunopharma overvalued?
According to Wall Street analysts Lyell Immunopharma’s price is currently Undervalued.
Does Lyell Immunopharma pay dividends?
Lyell Immunopharma does not currently pay dividends.
What is Lyell Immunopharma’s EPS estimate?
Lyell Immunopharma’s EPS estimate is -$0.21.
How many shares outstanding does Lyell Immunopharma have?
Lyell Immunopharma has 254,096,310 shares outstanding.
What happened to Lyell Immunopharma’s price movement after its last earnings report?
Lyell Immunopharma reported an EPS of -$0.205 in its last earnings report, beating expectations of -$0.23. Following the earnings report the stock price went up 2.817%.
Which hedge fund is a major shareholder of Lyell Immunopharma?
Among the largest hedge funds holding Lyell Immunopharma’s share is EntryPoint Capital, LLC. It holds Lyell Immunopharma’s shares valued at 127K.
---
Lyell Immunopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (150.00% Upside)
$6.00 (150.00% Upside)
Blogger Sentiment
Bullish
LYEL Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 68.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1.69%
12-Months-Change
Fundamentals
Return on Equity
-31.53%
Trailing 12-Months
Asset Growth
-20.00%
Trailing 12-Months
Company Description
Lyell Immunopharma
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors.
---
LYEL Stock 12 Months Forecast
Average Price Target
$6.00
▲(150.00% Upside)
Technical Analysis
Best Analysts Covering LYEL
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
-0.49%
reiterated a buy rating 2 months ago
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of -0.49% per trade.
---